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J  chain is a  15 kilodalton protein that links together IgM or IgA monomers to 
form pentameric  IgM or dimeric IgA (reviewed in reference  1).The regulation 
of J  chain  expression  in  B cells has been studied by several laboratories  in  an 
effort to  understand  the  developmental  program  of gene  activation  in  the  B 
lymphocyte. Some results suggest that the program  for J  chain expression may 
be different between mouse and  man.  Studies of mouse cell  lines representing 
different stages of B cell differentiation  have suggested that J  chain expression 
is a  late step of mature B cells; J chain appeared to be absent at the pre-B stage 
and in cells representative of unstimulated B cells (expressing surface IgM only), 
but present in large amounts in plasmacytomas and in mitogen-stimulated splenic 
lymphocytes (2-5).  In  contrast  to this  pattern  for mouse lymphocytes, several 
reports have indicated that human lymphocytes may begin J  chain expression at 
an earlier stage (6), perhaps even before synthesis of Ig (7). 
To  further  characterize  J  chain  expression  in  human  lymphocytes and  to 
extend the analysis to the DNA level, we have obtained genomic clones for the 
humanJ chain gene. The cloned gene has been examined by nucleotide sequence 
analysis  to  establish  its  identity  as  a  functional  J  chain  gene.  The  resulting 
sequence  has  been  compared  with  the  previously  published  human  J  chain 
sequence,  determined  at  the  amino  acid  level,  and  with  a  murine  J  chain 
complementary DNA (cDNA) 1 clone. Because of the presence of nine candidate 
polyadenylation signals  (AATAAA  or AATTAAA)  downstream  of the  C-ter- 
minal  coding block in  the  human  clone,  the  3'  end  of the  gene  could not be 
established from the sequence alone; S1  nuclease protection experiments using 
RNA  from  the  B  lymphoid  line  BALM-4  have  allowed  identification  of the 
functional polyadenylation site. Hybridization probes from the clone have been 
used to explore the human  genome (by Southern blot experiments) for related 
sequences.  Finally,  in  initial  experiments  investigating  the developmental  pro- 
gram  of this  gene,  a  cloned J  chain  probe  bas  been  used  to  analyze J  chain 
transcripts  in  a  variety of human  lymphoid cells representative of pre-B and  B 
cell stages of differentiation. 
Materials and  Methods 
Cloning  Methods.  The clones HuJ1 and HuJ2 were constructed by inserting  agarose 
gel-purified  (Bull's  Eye apparatus,  Hoefer Scientific  Instruments,  San  Francisco,  CA) 
z Abbreviations used in this paper:  cDNA, complementary DNA; mRNA, messenger RNA. 
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restriction endonuclease fragments into phage arms, and packaging (8) using a commercial 
extract (Packagene,  Promega  Biotec,  Madison,  WI).  For  HuJ1,  Barn  HI fragments of 
human placental DNA were ligated into Barn HI arms of Charon 28; for HuJ2, Eco RI 
fragments of DNA from the cell line REH (9) were ligated into Eco RI arms of ~gtWES. 
Clones were screened by the in situ hybridization method of Grunstein and Hogness (10) 
using a  330 basepair Bam HI-Hinf I fragment from the mouse J  chain cDNA clone (3, 
11) as a probe. 
Sequence Analysis.  Subciones of phage DNA fragments hybridizing to the mouse cDNA 
probe were constructed  in  pBR322  or pBR327,  and were sequenced  by the chemical 
degradation method of Maxam and Gilbert (12),  or, after subcloning into M13  vectors, 
by the dideoxy terminators method of Sanger et al. (13). 
S1 Nuclease Analysis.  The 3' end of the messenger RNA (mRNA) encoding the human 
J  chain was determined by the S1  nuclease method of Berk and Sharp (14) as presented 
in Maniatis et al. (15) with modifications. In a typical experiment, 20 t~g of total cellular 
RNA from the J  chain-expressing B cell line BALM-4 was coprecipitated with a double- 
stranded DNA probe labelled at one 3' end. The nucleic acids were resuspended in  10 #1 
hybridization buffer (40 mM PIPES, pH 6.4, 1 mM EDTA, 0.4 M NaCI, 80% formamide) 
and incubated at 72°C for 15 min, 43°C for 30 min, 27°C for 30 rain and 20°C for 2 h. 
Aliquots (5 ~tl) were diluted into 50 ~l of S1 buffer (0.28 M NaC1, 0.5 M sodium acetate, 
pH 4.6, 4.5 mM ZnCI2, 20 ~g/ml heat-denatured salmon sperm DNA) with or without S1 
nuclease (20 U/ml) (Bethesda Research Laboratories, Gaithersburg, MD), and incubated 
at 20°C  for  1 h. The reaction was stopped by chilling on ice.  10 #1 of 4  M ammonium 
acetate, with  100  mM EDTA was added, and the nucleic acids were extracted with  1:1 
phenol/CHCl3, precipitated with isopropranoi, resuspended in formamide loading buffer, 
and electrophoresed on a denaturing 6% acrylamide-urea gel. 
Southern Blots.  Human placental  DNA  was digested  with  restriction  endonucleases 
(Bethesda Research Laboratories, or New England Biolabs, Beverly, MA), electrophoresed 
(10 ~tg/lane)  on 0.7%  agarose gels, and blotted onto nitrocellulose (Millipore,  Bedford, 
MA) by the method of Southern (16). The blots were hybridized to nick-translated probes 
in a formamide-dextran sulfate buffer (17). 
J Chain Expression in Lymphoid Cells.  18 well-characterized cell lines or leukemias were 
examined for the presence of J  chain sequences in total cellular RNA.  NALL-I, HPB- 
Null, NALM-6, NALM-16, REH, and NALM-1JR are B cell precursor lines established 
from acute lymphoblastic leukemia or chronic myelogenous leukemia. Their Ig expression, 
Ig gene configuration, and B cell-associated surface antigens are listed in Table I and 
have been reported previously, in part (9,  18).  HL-60 is a promyelocytic leukemia (19) 
and  RPMI  8402  a  T  cell acute  lymphoblastic leukemia; both retain  germline Ig gene 
configuration (9). CLL-DC is a u, 1~ surface Ig-positive chronic lymphocytic leukemia that 
does not secrete Ig (20).  BHM-23 (21), RPMI 8392 (21), B85 (21) and SUDHL-6 (22) are 
IgM-secreting cell  lines.  SB26-11  (21)  and  BALM-4  (23)  secrete  IgG;  Arr2.5/2  and 
Arr2.2/11  (spontaneous B cell lines from a lymph node; Z. Landow, unpublished obser- 
vations) and  GM1056  (Human  Genetic  Mutant  Cell  Repository, Camden,  NJ) secrete 
IgA. Examination of Ig gene configuration in these cells was accomplished by Southern 
blots using a 2.2 kilobase (kb) Sau 3AJH probe, a  1.3 kb Eco RI Ct~ probe, a 2.3 kb Hind 
[[I-Sma I C'~ probe, a 2.5 kb Eco RI CK probe, and a 0.8 kbase Bgl II-Eco RI C~,I probe, 
as previously described (9).  Total cytoplasmic RNA (5-10 ug/lane), isolated from these 
ceils by the guanidine isothiocyanate method of Chirgwin et al. (24) was electrophoresed 
in 0.7% agarose-formaldehyde gels (15), blotted onto nitrocellulose or Gene Screen Plus 
(New England Nuclear, Boston, MA) and hybridized to nick-translated probes. 
Results 
Cloning  the  Human J  Chain  Gene.  The  substantial  homology  between  the 
amino acid sequence  reported  for the  human J  chain protein  and  that derived 
from nucleotide sequence of a mouse J  chain cDNA clone suggested that a probe 
from  the  mouse  clone  might  cross  hybridize  with  the  human  gene.  Initial J
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Southern blots of human placental genomic DNA hybridized with a 330 basepair 
Barn  H1  to  Hinf I  probe (11)  from  the  mouse cDNA (a generous gift of Dr. 
Marian  Koshland,  University of California,  Berkeley) demonstrated either one 
or two bands (depending on restriction  enzyme used) that  hybridized intensely 
to the probe.  Despite this  seemingly favorable result,  no genomic clones were 
obtained  on  screening  of several  gene  libraries  of human  DNA.  Each  screen 
encompassed 8-10 ×  10 ~ plaques; libraries were constructed from partial Mbo I 
digests of DNA from human cell lines or tissues, cloned into the Barn HI site of 
Charon 28. Each library had already been successfully screened for other genes. 
As  an  alternative  approach,  Barn  H1  fragments  of human  DNA  were  size- 
fractionated by preparative agarose gel electrophoresis, and a  7.5 kb positively 
hybridizing  fraction  was  ligated  into  Bam  Hl-cut  arms  of Charon  28,  and 
packaged.  One clone isolated from this enriched  material,  HuJ 1, was found by 
nucleotide sequence analysis to contain the two 3' exons of a gene encoding the 
human J  chain.  In  an attempt  to obtain  the remaining  5'  region  of the gene, 
probes from this clone were used for several additional library screens, but once 
again  no  isolates  were identified.  Therefore,  we  ligated  into  phage  arms  and 
packaged a preparative agarose gel fraction of 8 kb Eco R 1 fragments that was 
expected (on the basis of genomic  Southern  blots) to contain  a  DNA segment 
overlapping the Barn  H1  clone but extending further  5'  (see Fig.  1, top). The 
packaged  phage  were  screened  with  a  probe  from  the  5'  end  of HuJ1.  One 
resulting clone, HuJ2, was found to contain an exon encoding the remainder of 
the sequence of the mature J  chain protein. 
The Human J Chain Gene.  The three exons from the cloned DNA segments 
(see Fig.  I) encode an amino  acid sequence very similar to the one previously 
determined  from  chemical  analysis  of  the  protein  by  Mole  et  al.  (25)  and 
homologous with the murine sequence determined from a cDNA clone (11) (Fig. 
2). The N-terminal amino acid is glutamine,  consistent with the blocked pyrrol- 
idone carboxylic acid found at the protein level (25); this residue is absent from 
the  murine  protein.  Presumably a  signal  peptide  is  encoded in  an  exon  lying 
upstream; this would correspond to the situation in mouse (M. Koshland, personal 
communication), and would be consistent with the presence of an appropriately 
located "...AG" (ending at position 228 of Fig. 1) that is similar to the consensus 
sequence for mRNA splice acceptor sites (26). 
The J  chain sequence contains eight cysteine residues that are thought to play 
an important  role in the linkage of Ig monomers. The sequence deduced from 
the human gene reveals that all  of the cysteine residues are at positions homol- 
ogous to the cysteines in  the  murine  sequence (Fig.  2).  Although  the  protein 
sequence reported by Mole et al. (25) also deduced eight cysteines, the cysteine 
at residue 101 of our sequence was not identified by them, and residue 89 (serine 
in  both our sequence and  the  murine  sequence) was identified as cysteine (see 
Fig.  2).  In  addition  to  the  cysteine  residues,  a  glycosylation site  (asparagine- 
isoleucine-serine, residues 49-51) is conserved between the human and murine 
sequences.  The  lengths  of the  two  amino  acid  sequences  are  identical,  137 
residues.  The  absence of the  N-terminal  glutamine  in  the  murine  sequence is 
compensated by the insertion of an extra aspartate after residue 95 of the human 
sequence,  in  a  region  that  is  poorly  conserved  between  the  two  sequences. 0 
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CCCAGATTCCCATAGACTSGTTCAAGAAAAAAGTGAAAATCCCTTTTAGAGTAC:CTTTGGATT  TCCTTT ACTGTGATGTAAGAT  T CTGC  TTAGAGAACAA 
I  I  I  I  I  I  I  i  I 
A TGGAGAAAGCTGAGACAAACCAACCATAAAAXT  ATTT TTCTGCAGGCAAGAAAGATAAAATAACTCAAT  ACAAAATA T ATAA J,T T GACCTT T GT TTT CC 
I  I  L  I  I  I  I  I  I 
T T TCTTTTT  AATACGTTTACCTTTCAAGCCCAAGAAGATGAAAGGATTGT  TCTTGTTGA~.AACAAkTGTAAGTGTGCCCGGATTACTTCCAGGATCATCC 
GlnGluAspGluArgI|eValLauValAsDAsnlysCysLysCysA1aArgIleThrSQrArgllmlleA 
I  I  I  I  I  I  l  I  I 
GTTCTTCCGAAGATCCTAATGAGGACAT  TGTGGAGA8AAACATCCGAATT  ATGTATGTGQCATTCCAT  ATTCCTT TTTT TCCTC-TTCTAAGCAGAGAT AC 
rgSerSerGluAspProAsnGluAspIleValGluArgAsnl  leArgl lel I 
I  I  I  I  I  I  I  I 
TTTCTGACA~TGAG~ATTGTTTG~ATGTAA~A~CTG~TCTTTACTTCCCTTTTT~CTGTGTAG~ACTTTACATGAGTAAAGAATTGAGTCTTATGAATG 
I  I  I  I  I  I  I  I 
AGCTTGAGGCAATTTTATTGAAATTAGGGGTAAGAAATGAAAGATTACAGCCAATCTAAAAATCAAGTGTGCT  ACAT CAAAT TATAAACAAAGGT  T GTA A 
I  I  I  I  I  I  I  I 
TCTAGTCATCAACAATGCACTr-TTTATATGGXXTTATTTCTATACATTTATTTTTGTTT  8CT TGTTT TTGAGACAGGGT(::TCAAC TCT 8TCACCCAGGCT 
l  I  I  I  I  I  I  I 
AGAGTGCAGTGGCAAGATTAXGCTTACTGCAG  ..............................  --  ~  kb  ......................... 
....................................  GTATACTCATTACCAAAAATAACAATATCTGCATTTCATTGTTTTAACT  TTGTTTTCTTTCTTT 
I  I  I  I  I  I  I  l 
TCTTTT,i~GTGTTCCTCTGAACAACAGGOAGAATATCTCTGATCCCACCTCACCATTGAGAACCAGATT  TGTGTACCAT T TGT CTGACCTGTAAG~T  ATAT 
eValProLeuAsnAsnArgGluAsnlleSerAspProThrSerProLeuAr  iThrArgPheyalTyrHi  sLeu$~rAspLQ 
I  I  I 
TTTTTTCCATAGTAATATAGA~GT~GAAGTTAATA8CTTTTAAT~TTAACCT~GTTAGTAAGAATGTTTTTAAAAATATGTT~GAGTA~AAACATTTACA 
I  I 
AACATAATCTGAACTTTTGAATACATTAATTCCTATGTTAATTATTA8GTAT•ATAAATTCATAAAA•TTT•TCACAGATAAAATTTAGCTATACATTTT 
I  I  ; 
TTCTAk~GAAAAAATCATTGGCATT  CATAGAAAGGCCAATTTCTCTTAATAGTTCAATAAGTGXATTTGATCTTAT  AAAAAGGCAGGT GTTT CTTTGGAA 
I  I  I 
ATGACAGACTCCAACATCAATTTTTTTAAAAATTCTCCCTT  TCTTGTCACTATAAATAACTTGTTTAGACAGAT  ATACAGT TGGGAATAAGCCT AACACA 
8TAGAAATTGCTGTATG•TGTAGATAAAACAATCATATTATCATATCATTAATTATATTGCTTAC•TTCAACTAATATATATTAAAGATTGGAAAATCCC 
[  I  I 
ATAAGCTATTCTGTATTGTAGAGCTGCTTATGT•TGAAAGGA•TCATCCCTTGCTGTCATGTCAGAGCTG•AAGAACTAAT  T GA T T TTGGATTGAAA TGT 
I  I  I 
GTAGTCACATTTTGAGACAGCATTTGAGGGGATTGTCTAATACATATATT  TGCTTTTCAGCTGTAAAAAATGTGATCCT  ACAGAAGTGGAGCTGGATA AT 
uCysLyslysCysAspPr  oThrGl uVa 1G1 u LeuA spA sn 
I  I  I  I  l  I  I  I  I 
¢AG-~T AGTT A~T~TACCCAG/~GCA/~T  #,TCTGI"GAT GAAGA~AGTGCTACAGAGACCT GCT ACA~TTAT  G~C ~GA A~CAA~TG~T  ACAC A  GC~ GT GGT CC 
Glnl[ I eVa | ThrAlaThrGlnSer  A snI }.llCysA sl>GluAsl~SerAl ~ThrGluThrCysTyrThr  TyrA ~pAr 9A ~n Lv~CM~Ty r ThrA LaValVa 1 P 
I  I  I  I  l  I  I  )  I 
cAcTc8TATAT~G~GG~GAGAccAAAATn~TG~AAAcA~¢cTTAAc¢ccAGATG~TGcTATccT~AcTAATTTAA8TcATT~ToAcT~cATA~cTcTT 
roL  euVal  TTrGtyGlyGlTThrLysMe*Va  |  GluThrA  laL  euTh~P  roAspA  laCys  [yrProAsp 
TTTCTTGAGAGGCTCTCCATTTTGATTCA  ;AAAGTTAGCATATTTATTACCAATGAATTTGAAACCAGGGCTTTTTTT  TTT T TTTGGGTGATGTAAAACC 
AACTCCCTGCCACGAAAATAATT  AAAATAGTCACA  TTGTTA'r  CTTTATTAGGTAAT  CACT TCTTAATTATATGTTCATACTA  AGT/;TCAAAAT  CTTCCAA 
TTATCATGCTCACCTGAAAGAGGT  ATGCT, :TCT TAGGAA TACAGTT TCTAGCAT TAAACAAATAAACAAGGGGAGAAAA  T AAAACT CAAGGAGT GAAAA T 
CAG•AGGTGTAATAAAATGTT•CTCGCATTCCCCCCCGCTTTTTTTTTTTTTTTTGACTTTGC•TTGGAGAGCCAGAGCTTCCGCAT  TTTCTTTACTATT 
CTTTTTAAAAAAAGTTT~ACTGT8TAGAGAACATATATGCATAAACATAGGTCAATTATATGTCTCCATTAGAAAA~`TAATAATTGGAAAACATGTTCTA 
GAACTAGTTACAAAAATAATTTAAGGTGAAATCTCTAATATTTATAAAAGTAGCAAAATAAATGCATAATTAAAATATATTTGGACATAACAGACTTGGA 
AGCAGATGATACAGACTTCTTTTTTTCATAATCAGGTT  AGTGTAAGAAATTGCCATTTI~AAACAATCCATT  T TGT AACTGAA CCTTA TGA AAT AT AT GT A 
TTTCATGGTACGTATT•T•TAGCACAGTCTGAGCAATTAAATAGATTCATAA•CkTATACCTGTGTGAAATAAATTGT•GGAAAAAAGTTTCCTTATGTT 
AACTTTCTTTACGTAAGTTAACTTGT'TATTGATGAATGGTTTGTAAGTATGATGTAATGA  AGCATTAATCAC;AGA/~C7 AATAC:AT GTACAT AT TTGAGGT 
GGCTTTGCCATTTTATACCCATAATTAAATAAAAG~GCAAAATCCCCCCTGATAAATACCATGT~TATCATGGCACATAAAACT~TATGG~AGTTTCCAA 
GGCCAATTGACATATATATT  TAAA 
FIGURE  1.  Sequencing strategy and nucleotide sequence of the human J  chain gene. The 
map at top diagrams the two genomic clones analyzed. HuJ1  was obtained first, and was the 
source for sequence of exons three and four. HuJ2 contains exons two, three, and four, and 
was the source for sequence of exon two. The expanded map indicates only the restriction 
sites used  for  sequence  analysis.  Each  arrow  indicates an  individual sequence  run;  arrows 
starting at upwards-pointing vertical bars represent M13 clones sequenced by the Sanger et 
al. (13) dideo×y terminators method, while arrows starting at full vertical bars represent 3' 
end-labelled fragments sequenced by the chemical degradation method of Maxam and Gilbert 
(1 ~). Amino acid translation of the coding blocks is presented below the nucleotide sequence. 
The functional AATTAAA polyadenylation signal defined by S1 nuclease mapping is under- 
lined. 
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EXON  2 
10  20  30  ~0 
I  I  I  I 
QEDERIVLVDNKCKCARITSRIIRSSEDPNEDIVERNIRII 
....................  ///  ........  EIV-///-- 
D--ATI-A  ....  M-T-V  .....  P-T  ..............  V 
EXON  3 
837 
50  60 
I  I 
VPLNNRENISDPTSPLRTRFVYHLSDL  HUMAN  GEHE 
---D  .......................  HUMAN  PROTEIN 
.................  RN ........  MOUSE  eDNA 
EXON  ~. 
70  80  90  95  96  100  110  120  ~30  157 
I  I  I  I  I  I  I  I  I  I 
CKKCDPTEVELDNQIVTATQSNTCDED  SATETCYTYDRNKCYTAVVPLVYGGETKMVETALTPDACYPD  HUMAN  GENE 
--X  .................  CB ....  N  X-X-X//  .......................  Z .....  B ....  B  HUMAN  PROTEIN 
......  V ....  ED-V  .........  V--DGVP  ....  V ........  TM---R-H  ......  qA .....  S ....  MOUSE  cDNA 
FIGURE 2.  J  chain amino acid  comparisons.  The  sequence of the  mature  human J  chain 
protein deduced  from the gene is presented, divided into the three coding blocks of exons 
two, three, and four. For comparison, the chemically determined amino acid sequence of the 
J  chain protein is presented below.  Dashes represent residues identical to those of the gene- 
defined sequence; (/) represents residues omitted from the sequence. The third line gives the 
amino acid sequence deduced from a  mouse cDNA clone (11), incorporating the correction 
identified by Elliot and Steiner (45). 
Although the possibility ofgene polymorphism as an explanation for the discrep- 
ancies between our sequence and that of Mole et al. (25) has not been rigorously 
excluded, it seems likely that the latter study concluded that the human J  chain 
is  129 amino acids long because two arginine  tripeptides  (residues  22-24  and 
37-39),  as well as  residues  101  and  102,  were missed in  the  analysis.  If each 
insertion/deletion between the mouse and human amino sequences is counted as 
a  single substitution,  then  there are  31  amino acid changes in the  137-residue 
sequence, or about 77% amino acid concordance between the two J  chains. 
We believe that our cloned DNA segment corresponds to a functional J  chain 
gene.  The  nucleotide  sequence of Fig.  1 contains  all  expected  mRNA splice 
signals, no termination codon until the expected end of the amino acid sequence 
(TAA at position 1,869) and an appropriate polyadenylation signal (AATTAAA 
at position 2,635, as discussed below), so it is a  good candidate for a  functional 
gene. Since the nucleotide sequence encodes an amino acid sequence very similar 
to that previously reported for the human J chain, probes from this clone should 
certainly  hybridize  to the  functional J  chain  gene.  Genomic Southern  blots of 
human  DNA  probed  with  DNA  fragments  from  our  clone  identify  only  two 
hybridizing bands.  One corresponds  to the cloned gene,  while the other dem- 
onstrates  homology apparently confined to exon four (as discussed below), and 
thus could not encode a complete J  chain.  For these reasons, we conclude that 
the exons we have cloned derive from a single functional gene for the human J 
chain. 
Polyadenylation Signal.  The 3' end ofeukaryotic mRNA is generally signalled 
by the  hexanucleotide  AATAAA,  or the  variant  AATTAAA,  found  ~20  nu- 
cleotides 5' of the poly(A) tail in most mature mRNA. The human J  chain gene 
reveals nine candidate polyadenylation signals (AATAAA or AATTAAA) in the 
sequenced region downstream of exon four (Fig.  1), leaving the position of the 
3'  end of the gene ambiguous.  The homology between the mouse and human 
genes in  the 3'  untranslated  region  is much  less than  in  the coding sequences, 
but there  is  sufficient similarity  to  identify  in  the  human  sequence the  AAT- 
TAAA  homologous to  the  polyadenylation  signal  in  the  mouse (Fig.  3).  This 838  HUMAN J  CHAIN  GENE 
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HUMAN  AATCCATTTTGTAACTGAACCTTATGAAATATATGTATTTCATGGTACGTATTCTCTAGCACAGTCTGAG~AATTAAATAGATTCATAAGCATATA 
I  II  I  I  I  II  II  IIIIII  I  [lllll  II  II  IIIIIIIIIII  IIIII  III  IIIIIIIIIIII  I  IIIlllll 
HOUSE  CTTTGATGTCTCAGCCAAATCTAATGAAA TTTGTATTCCAAAATATGTATTCTCTAGTACAGTTTGAACAATTAAATAGAGTGCTAAGCATAAAAAAA 
FIGURE 3.  Dot-matrix  comparison  of exon four of human and mouse J  chain nucleotide 
sequences. Sequence homology between the two nucleotide sequences was displayed by a dot- 
matrix  program similar to that described by Maizel and Lenk (46). In such a program, two 
sequences to be compared are linearly arrayed in computer memory as if one were strung on 
the X axis and the other on the Y; for every point (X, Y) in the matrix, the computer compares 
the corresponding sequences on the two axes, and places a dot at (X, Y) if the sequences meet 
a specified criterion of similarity. For the present matrix,  the criterion for a dot was eight 
nucleotide matches in a window of 10 basepairs. The sequences compared represent the entire 
exon four, i.e. the fourth coding block (represented  by black rectangles on the axes at upper 
left) and 3' untranslated region. The markers  on the axes represent 20 basepair  intervals. 
Only short homology diagonals are present in the 3' untranslated region.  The insert below 
shows the sequence represented by the bars on the axes at lower right; this region corresponds 
to the 3'-most homology diagonal,  including the sequences flanking the AATTAAA poly- 
adenylation signal in both species. 
sequence occurs at  position 2,635  (Fig.  1),  766  basepairs  from  the  end of the 
coding sequence, and is the seventh of the nine polyadenylation  signal candidates. 
In the mouse cDNA clone, the DNA segment between exon four and the poly(A) 
tail contains only the one functional polyadenylation signal. To define the 3' end 
of the human J  chain gene and determine whether the AATTAAA  homologous 
to the murine signal was the functional one, S1  nuclease mapping was used (see 
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Either of two  3'  end-labelled DNA probes  was hybridized with  total  RNA 
from BALM-4, a human B cell line documented by Northern blotting to contain 
abundant J  chain RNA. The RNA-DNA hybrid was treated with S1  nuclease, 
and the samples were run on a denaturing gel to measure the size of the DNA 
protected from S 1 digestion. The formation of RNA-DNA hybrids is favored by 
high G-C content. Probe A, an Xba I-Aha III  fragment of 524  basepairs, was 
extremely A-T  rich  (G-C  content  only  29%),  and  so  the  S1  protection  was 
difficult to detect.  Nevertheless, on overexposed gels a  band at 260  basepairs 
was reproducibly found after  RNA  hybridization and  S1  treatment,  but  was 
absent in control experiments (left panel, Fig. 4).  To verify this S1  protection, 
the experiments were repeated with probe B. This 1,106 basepair fragment had 
a slightly higher overall G-C content (32%), but included a  72 basepair portion 
of coding sequence with a G-C content of 51%.  In addition to its potential for 
stronger hybridization, this probe was capable of detecting transcripts ending at 
the four upstream polyadenylation candidates. As shown in the middle panel of 
Fig. 4, probe B detected only a single large transcript. When this band was sized 
by running the gel further (right panel), the end of the transcript coincided with 
that detected by the shorter A probe; this position is approximately at nucleotide 
2,660  (Fig.  1)  about  20  basepairs  3'  of the  AATTAAA homologous to  the 
polyadenylation signal found in mouse. 
A Second Homologous Sequence.  Initial genomic Southern blots of human DNA 
digested with various restriction enzymes demonstrated, for most enzymes, two 
bands hybridizing with a probe from the mouse J  chain cDNA clone. Character- 
ization of the human J  chain gene allowed identification, for each enzyme, of 
the band contributed to the Southern blot by this gene. A  map could then be 
constructed of the "extra" bands. To determine the extent of homology between 
the J  chain gene and this extra homologous sequence, probes derived from the 
cloned gene were hybridized to Eco RI digests of human DNA. In such digests, 
the functional J chain gene corresponding to our clones appears as an 8 kb band, 
and the second homologous sequence as a 4.5 kb band. As shown in Fig. 5, the 
4.5  kb  band  hybridizes to  probes  containing exon  four,  the  3'  untranslated 
region, and 3' flanking region (probes B through F) but not to probes 5' ofexon 
four (probe A). Thus,  the 4.5  kb band does not appear to contain a  sequence 
homologous to exon three. An alternative explanation is that the extra sequence 
might represent an intact gene that is cut by Eco RI  such that its exon three 
resides on  an  8  kb  Eco  RI  fragment fortuitously comigrating with  the  8  kb 
fragment containing the cloned gene. This possibility is diminished by the fact 
that only a single band hybridizing to probe A is also apparent in an Eco RI/Sst 
I  double-digest  (Fig.  5).  It  is  unlikely that  two  sequences would yield bands 
comigrating under both digestion conditions. Full characterization of the second 
hybridizing sequence will  require cloning and  sequence analysis of this  DNA 
segment. 
Several probes derived from the cloned gene in the region flanking exon two 
contain reiterated sequence, as judged by the intense smear they produced on 
hybridization to genomic Southern blots. One reiterated sequence identified by 
nucleotide sequence analysis is an Alu repeat (27), which begins around position 
640 of Fig.  1, and extends downstream into a  region of the clone that has not 840  HUMAN J  CHAIN  GENE MAX  AND  KORSMEYER  841 
been sequenced. A  computer search of the GenBank (Bolt, Beranek, and  New- 
man, Cambridge,  MA) library revealed no other sequence homologies of appar- 
ent significance. 
J Chain Gene Transcription in Human Cells of  B Lymphocyte Lineage.  To initiate 
our investigation  of J  chain  regulation,  we have used Northern  blot analysis to 
examine J  chain  RNA  in  several  human  cell  lines  and  tumors  representing 
different stages of B lymphocyte development. Total cellular RNA from selected 
cells  was  electrophoresed  on  a  formaldehyde-agarose  gel,  blotted  onto  Gene 
Screen  Plus or nitrocellulose  membranes,  and  probed with  the  -600  basepair 
Pvu II/Xba I exon four probe from the HuJ1 clone. 
Fig. 6 and Table I reveal that J  chain may be transcribed as early as the pre-B 
cell  stage  in  humans.  Both  HPB-Nuil  and  NALM-1JR  are  well-characterized 
human  B  cell  precursor  lines  that  contain  cytoplasmic  t~  chain,  but  do  not 
synthesize light  chain  or  secrete  Ig;  yet they are  strongly positive for J  chain 
mRNA. However, J  chain mRNA was not apparent in four of the six pre-B-like 
lines  examined.  Of  these,  three  demonstrated  no  cytoplasmic  ~  (NALL-1, 
NALM-16, REH), and only one (NALM-6) was positive for cytoplasmic ~. Thus, 
while the J  chain gene clearly can be transcribed at the B cell precursor stage, J 
chain  mRNA  is  not always present  in  all  such  human  cells,  appearing  in  our 
sample only in those cells with cytoplasmic u. Of the ten lines we examined that 
were representative  of mature  B  cells,  eight,  incuding  all  of the  IgM  or  IgA 
secretors,  contained J  chain  RNA easily detectable in  samples of total  cellular 
RNA. The correlation of  J  expression with heavy chain isotype (i.e., J  expression 
in  cells making  #  or a) is not strict;  BALM-4, a  3', K cell, contains abundant J 
message, whereas none was apparent in our blot of RNA from the #, ~ cell CLL- 
DC.  The  lack  of detectable J  chain  message  in  the  latter  cell  may  reflect  a 
developmental  stage slightly  less mature  than  that  of the other  B  cell  lines  in 
that,  typical of CLL cells,  it  displays surface  Ig but does not secrete  Ig.  Such 
nonsecreting  B cells would not synthesize pentameric  IgM, and would have no 
apparent need forJ chain protein. 
RNA from two cell lines not in the B lymphocyte lineage,  the promyelocytic 
line HL-60 and the T  cell line 8402, showed no hybridization to ourJ probe, as 
expected. 
The J  chain  mRNA was observed as a  single band that migrates at the same 
position in all cells with a detectable transcript.  This result is consistent with the 
single functional polyadenylation site detected by S 1 nuclease analysis. The size 
FIGURE 4.  The  3'  end of the message as defined by S1  nuclease mapping.  Total  cellular 
RNA from the B cell line BALM-4 was hybridized to 3' end-labelled probe A (li~ft panel) or 
B  (middle panel) as described in Methods.  Samples were treated with S1  nuclease and run 
(with controls) on denaturing urea-polyacrylamide gels. As size markers, samples of the same 
probes were cut by restriction enzymes Dde I, Hinf I, Rsa I, and Hpa I (partial digestions were 
used in the case of the longer probe B), and run on the same gels. The last lane of the middle 
panel was duplicated in the first lane of the right panel; this gel was run much longer in order 
to compare the protected band with the size marker bands shown in the remaining lanes of 
this panel.  The  map below  illustrates the relationship of the two  probes to the exon  four 
coding block of the gene (black rectangle), the nine candiate polyadenylation signals, and the 
restriction sites used in the analysis. The boxed AATTAAA sequence is homologous to the 
polyadenylation signal in the mouse cDNA clone (Fig. 3). The gels indicate a single protected 
fragment terminating at a  position 260 nucleotides from the labelled Xba I end of probe A 
and 860 nucleotides from the labelled Ava II end of probe B. 842  HUMAN  J  CHAIN  GENE 
FIGURE 5.  An additional sequence in human DNA that hybridizes to exon four probes from 
the J  chain gene. Human placental DNA was digested by the indicated enzymes, electropho- 
resed in agarose gels, transferred to nitrocellulose, and hybridized with probes derived from 
the cloned human J  chain gene. Lanes from several experiments have been assembled for this 
figure; this explains slight differences in the migration of the bands. The probes,  indicated 
below each lane, represent DNA segments from around exons three and four, as shown in the 
map at bottom. In the map, black rectangles represent the coding blocks; the hatched rectangle 
represents 3' untranslated region. The cloned gene corresponds to the 8 kb Eco RI band and 
the 7.3 kb Eco RI/Sst I band seen in the blots. The 4.5 kb Eco RI band represents another 
sequence in the human genome that contains enough similarity with exon four of theJ chain 
gene to hybridize with these probes. The sharp lines near the bottom of several lanes are edge 
artifacts resulting from cutting the blots. FIGURE 6.  J  chain sequences in RNA from human cells.  Total cellular RNA was used for 
Northern blots hybridized to the Pvu  lI/Xba I J  chain probe. The cell lines are identified 
above each  lane;  the  Ig isotypes synthesized by  the  B  cell  lines are  indicated. The  spots 
appearing in the NALM-6 lane and the six right-most lanes are believed to be hybridization 
artifacts; the faint band slightly above the position of the J  chain mRNA in the GM 1056 and 
CLL-DC lanes apparently represents residual binding to 18 S RNA, which migrates exactly at 
this position. In these experiments, an attempt was made to load consistent amounts of RNA 
on the gels and to follow standardized protocols for blotting, hybridization, etc. However, no 
attempt at quantitation has been made, nor have we determined the detection limits of our 
blotting technique in terms of numbers of RNA molecules per cell. 
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of the hybridizing  RNA (estimated from the migration  of transfer  RNA,  18 S 
RNA, and 28 S RNA on the same gels) was ~1,500 nucleotides. 
Discussion 
The  cloning  of  the  human  gene  encoding  the  J  chain  protein  has  been 
accomplished, with some difficulty, owing to the apparent  absence of the gene 
in several gene libraries.  Failure of a  gene to be represented in a  given library 
may, theoretically, be explained by peculiar distribution of sites for the restriction 
endonuclease originally  used  to generate  the  DNA fragments  from  which  the 
library  was constructed,  Mbo  I  in  our case.  The  fact  that  all  the  libraries  we 
screened were amplified is consistent with the alternative possibility that the gene 
is  associated  with  sequences  that  handicap  phage  multiplication  during  the 
amplification  step.  Such  hypothetical  sequences did not,  however, prevent the 
growth of the clones we isolated from size-fractionated restriction fragments. 
The identification  of the DNA segment contained in the overlapping clones 
HuJ1 and HuJ2 as deriving from a functional gene for the humanJ chain protein 
is based on the facts that (a) the cloned segment encodes an amino acid sequence 
nearly  identical  to  that  previously reported  for this  protein,  and  (b) Southern 
blots of human genomic DNA reveal no other candidate for a related gene that 
could  encode  the  complete  protein.  The  "extra"  band  of Fig.  5  apparently 
represents a sequence closely similar to exon four of the functional gene. It seems 
unlikely that  this  extra  band represents a  short,  fortuitous sequence similarity 
without real homology, because the hybridization is so strong, and because it is 
detected by nonoverlapping probes that span more than 0.5 kb. The band is not 
likely to represent a  "processed pseudogene" (28) because it does not hybridize 
to probe A, which contains all of exon three.  One intriguing  possibility is that 
the presence of exon four in both the J  chain gene and in the extra band may 
represent an example of the evolutionary exon shuffling postulated by Gilbert 
(29) as an explanation  for the splitting of eukaryotic genes by noncoding intron 
sequences. In the framework of this model, exon four may be functioning as an 
exon in another gene, whose remaining  structure may be completely unrelated 
to the J  chain  gene.  Alternatively,  the extra band may represent  a  duplicated 
copy of theJ chain gene that has undergone a substantial deletion. An evaluation 
of these possibilites awaits analysis of the extra hybridizing sequence. 
An  unexpected  feature  of the J  chain  gene  was  the  existence  of multiple 
potential  polyadenylation  signals  3'  of the  final  coding  block.  The  sequence 
AATAAA was first recognized as a polyadenylation signal by its appearance near 
the  3'  end of many RNA sequences (30).  Subsequently, it has been shown,  in 
several systems, that mutations in this hexanucleotide can prevent normal cleav- 
age  and  polyadenylation  of RNA  transcripts  (31).  AATAAA,  or  the  variant 
AATTAAA found in several genes, is apparently necessary but not sufficient as 
a functional signal. That it is not sufficient is demonstrated in the human J  chain 
gene  by the  presence  of nine  such  sequences,  only  one  of which  appears  to 
function as a true polyadenylation signal in BALM-4, as shown in Fig. 4. Multiple 
polyadenylation  signals  have  been  reported  in  several  other  genes  in  which, 
however, more than one of these signals is generally functional [e.g.  mouse/32- 
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mouse dihydrofolate reductase (35)].  In the Ig heavy chain genes the function 
of alternate polyadenylation sites is specifically regulated during maturation of 
the cell (36); this raises the formal possibility that, in the human J  chain system, 
different polyadenylation signals might be functional under some circumstances. 
The fact that the functional signal observed in BALM-4 is the only one of the 
nine candidates showing flanking homology with the single signal found in the 
murine J  chain  cDNA studied by Cann  et al.  (11)  suggests that  this  flanking 
homologous segment may contain sequences that contribute to the signaling for 
cleavage and polyadenylation. This homologous segment is 5' of the AATTAAA 
found in both genes (Fig. 3); whether significant homology is also present further 
3', in a sequence that (at the RNA level) is replaced by poly(A), is unknown at 
present because a genomic sequence of this region of the mouse gene is not yet 
available. Sequence comparisons of the 3' regions would be particularly interest- 
ing because experiments in several systems (e.g. bovine growth hormone [37], 
adenovirus E2A transcript [38], hepatitis B surface antigen [39], and SV40 late 
messages [M.  Sadofsky and J.  Alwine, personal communication]) suggest that 
sequences 20-60  basepairs 3'  of the AATAAA are critical in determining the 
position of poly(A) addition. No evidence has yet been obtained for function of 
a  sequence  upstream  of the  AATAAA  signaling  the  region  where we  find 
sequence conservation between mouse and human J  chain genes, but a role for 
this region cannot at present be ruled out. 
Developmental Program of J  Chain Expression.  The observation  that  several 
mouse lymphoma lines with characteristics of early B cells make no detectable J 
chain or J  chain mRNA (2-5) has been taken to indicate that in mouse, J  chain 
synthesis is a  late-developing function in  the maturation of the B  lymphocyte. 
Some studies (40) have supported this notion for human B cells. Thus Mestecky 
et al. (40) did not detect J chain in either pre-B or B cells, but found that synthesis 
of J  chain and Ig appeared simultaneously after pokeweed mitogen stimulation 
of B lymphocytes, as if expression of J  chain and Ig were regulated in a  linked 
manner. These results fit in an appealing way with the fact that the only known 
functions of the J chain involve interaction with Ig: the formation of Ig multimers 
(IgM  pentamers  and  IgA  dimers),  and  the  facilitation  of  binding  of  these 
molecules to  secretory component (1,  41).  Thus,  a  simplistic expectation of J 
chain expression might predict synthesis of  J chain only in lymphocytes requiring 
these functions (i.e., those secreting lgM or IgA). Consistent with this viewpoint, 
we found that a nonsecreting but IgM-bearing chronic lymphocytic leukemia cell 
lacked detectable J  chain RNA, while all the IgM- or IgA-secreting B cell lines 
that we examined contained it. 
However, accumulating evidence suggests that,  in  humans at  least, J  chain 
expression may not always be tightly linked to Ig expression. Mason and Stein 
(42),  for  example,  identified  intracellular J  chain  (by  immunohistochemical 
staining) in  three Ig- human lymphomas, as well as in  occasional Ig- cells in 
reactive lymph node biopsies. McCune et al. (6) used in vitro translation of RNA 
and immunoprecipitation to document J chain expression in a pre-B-like cell line 
and two Ig- round cell lines. Hajdu et al. (7) examined J  chain by radioimmu- 
noassay and immuno-electron microscopy, and suggested that J chain expression 
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Our  Nothern  blot  analyses  show  that,  although  four  of the  cells  of pre-B 
phenotype  we  examined  do  not  express  detectable J  RNA,  two  pre-B  RNA 
samples contain  abundant J  chain  sequences (Fig.  6).  These  two J+ lines  have 
been  unequivocally characterized  as pre-B-iike:  they both express CALLA, an 
antigen lost on most mature B cells; they both express cytoplasmic but not surface 
u chains; and they both have their light chain genes in the germline configuration. 
These traits rule out the interpretation,  which can be entertained for some other 
cases ofJ  + Ig- cells, that they represent not pre-B cells, but mature B cells that 
have lost their  capacity to synthesize antibody.  The  model of Hajdu et al.  (7), 
suggesting  that J  chain  expression  precedes  #  expression,  was  based  on  the 
finding of immunoreactive J  chain in #- leukemic null cells, as well as in two •+ 
pre-B cell lines. Although  we have not examined fresh leukemic null cells, the 
six pre-B  lines that  we used for Nothern  blot analysis of J  chain  RNA do not 
support  such  a  model.  Given  the  absence  of a J+  ~-  line  in  our  set,  and  the 
presence of a J- t~  + cell (NALM-6), our data are more consistent with a model in 
which ~ expression precedes J  chain expression; but in consideration of the data 
of other investigators (7), it is probably most reasonable to conclude that no clear 
sequence of activation  of these two genes has yet been established for human 
lymphoid cells, if indeed such an invariant sequence exists. 
The observation of  J  chain expression in human pre-B lines is at variance with 
published results in the mouse. As indicated above, all results on murine lymphoid 
lines representing  the pre-B or early unstimulated  B cells are consistent with J 
chain being a  late characteristic  of mature,  stimulated B cells (5).  Conceivably, 
the  malignant  transformed  cells  that  are  generally  studied  (human  or  mouse) 
might not accurately reflect the phenotype of normal differentiating B lympho- 
cytes. The  process of transformation  and  maturation  arrest  could activate  or 
repress  specific gene  expression,  and  such  processes could operate  differently 
between the  two species.  Alternatively,  it  is also possible that  more  extensive 
studies of mouse pre-B cells will reveal some J  chain expression at stages earlier 
than has so far been observed. A most interesting possibility is that a real species 
difference may exist in the developmental program of gene expression of murine 
and human  B lymphocytes, but more evidence will be necessary to substantiate 
this. 
Of the  mature  B  cells examined  in  the  present  study, J  chain  message  was 
found in almost all. The absence of detectable J chain RNA in the nonsecretory, 
IgM-bearing CLL-DC is consistent with the phenotype of other early B cells such 
as WEHI  231  (43) and  unstimulated  murine  B lymphocytes (5) reported from 
Koshland's laboratory, and the comparable human CLL and lymphoma material 
reported by Laurent et al. (44). These cells suggest that the transcription  of the 
J  chain  gene  may  be  turned  off at  certain  periods  within  the  mature  but 
nonsecretory stage of B cell differentiation.  The presence of  J  chain RNA in an 
IgG-secreting  cell  argues  that  the  gene  may  continue  to  be  transcribed  after 
heavy chain class switching to C~, regions, even though the J chain protein is not 
utilized in secreted IgG. This confirms similar observations at the protein level 
reported by several laboratories (40, and references therein). 
The availability of a  human J  chain clone should allow the regulation  of this 
gene during B cell differentiation to be more finely dissected. MAX  AND  KORSMEYER  847 
Summary 
As part of an ongoing investigation of the regulation of gene expression in B 
cell development, we have obtained a genomic DNA clone encoding the human 
J  chain protein. The nucleotide sequence of exons encoding the mature protein 
defines a  137 amino acid primary sequence similar to that previously determined 
at the  protein  level.  Probes from the  gene have been  used to analyze J  chain 
expression in human cell lines corresponding to pre-B and B lymphocytes.J chain 
RNA was detected in two of six human pre-B cell lines and in 8 of 10 B cell lines 
expressing various Ig isotypes. The expression of the J  chain gene is, thus,  not 
tightly linked to IgM or IgA secretion. Our data do not, however, support the 
recent  suggestion  (7)  that  synthesis  of J  chain  precedes  that  of #  chain  in  B 
lymphocyte differentiation. Because of the presence of nine candidate polyaden- 
ylation signals (AATAAA or AATTAAA) downstream of the C-terminal coding 
block of the J  chain gene, the 3' end of the gene could not be determined from 
sequence  data  alone.  To  define  the  3'  end, J  chain  RNA  from  a  human  B 
lymphocyte line  was  used  to  protect an  end-labelled  DNA  fragment  from  S1 
nuclease digestion. The sequence 40 basepairs 5' of the functional polyadenyla- 
tion site identified by these S1  experiments is homologous the same region of a 
previously reported mouse J  chain complementary DNA clone. 
We are grateful to Dr. Marian Koshland for helpful discussions,  as well as the gift of the 
murine J chain cDNA clone; to Marion Hinners and Ann Kuo for expert and dedicated 
technical assistance;  and to Virginia Shaw for excellent and patient editorial assistance  in 
the preparation of this manuscript. 
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